Covalent labeling in combination with mass spectrometry
is a powerful
approach used in structural biology to study protein structures, interactions,
and dynamics. Recently, the toolbox of covalent labeling techniques
has been expanded with fast fluoroalkylation of proteins (FFAP). FFAP
is a novel radical labeling method that utilizes fluoroalkyl radicals
generated from hypervalent Togni reagents for targeting aromatic residues.
This report further demonstrates the benefits of FFAP as a new method
for structural characterization of therapeutic antibodies and interaction
interfaces of antigen–antibody complexes. The results obtained
from human trastuzumab and its complex with human epidermal growth
factor receptor 2 (HER2) correlate well with previously published
structural data and demonstrate the potential of FFAP in structural
biology